StemSation International Provides Corporate Updates
Rhea-AI Summary
StemSation International (OTC: STSN), a South-Florida based company, has provided corporate updates on their expanded business model. The company, which has licensed technology for flavored, canned oxygen products, is exploring new business initiatives. CEO Benjamin Silber stated that while they initially targeted green energy companies for acquisition, they are now focusing on opportunities in the consumer goods sector, particularly 'impulse buy' products for convenience store cash registers.
This shift aligns with recent data from the National Association of Convenience Stores (NACS), which reported record sales of $859.8 billion in 2023, including $327.6 billion from in-store sales. StemSation aims to leverage the sales advantage of register space, where customers have already committed to making a purchase. The company expects to provide additional updates on their business plan shortly.
Positive
- Expansion into consumer goods sector, focusing on 'impulse buy' products
- Potential acquisition of consumer products companies
- Alignment with growing convenience store industry, which saw record sales of $859.8 billion in 2023
- Strategy to leverage high-value register space in convenience stores
Negative
- Unsuccessful attempts to acquire green energy companies as initially planned
- Delayed roll-out of their own consumer goods products
News Market Reaction 1 Alert
On the day this news was published, STSN declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model
PLANTATION, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing new business initiatives for the upcoming months.
"We announced last year that we had streamlined our current business and would be seeking further licensing opportunities and asset acquisitions,” stated Benjamin Silber, CEO of StemSation International. “Working closely with advisors, we are concentrating on business segments with proven growth. While we had targeted green energy companies as our initial acquisition targets, we have not found the right fit yet for the company,” he continued. “As we work on the roll-out of our consumer goods products, we have found some opportunities in this space that allow for the current acquisition of consumer products companies while providing a distribution platform for future StemSation products. The focus would be ‘impulse buy’ products by the cash registers of convenience stores. We expect to have updates shortly as we move these projects forward,” he concluded.
According to newly released data from the National Association of Convenience Stores (NACS), convenience stores saw record sales in stores in 2023. Total convenience industry sales in 2023 were
StemSation expects to have additional updates shortly as they fulfill on their current business plan.
About StemSation International
StemSation International, Inc. (OTC PINK: STSN) is researching the developing, marketing and distribution of flavored, canned oxygen products. These products will be distributed in a lifestyle model to the beverage industry as well as colleges, restaurants and bars. StemSation is headquartered in Plantation, Florida.
SEC Disclaimer
his press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in StemSation international's ("the Company") business plan. The announcement of acquisition plans should not be construed as an indication in any way whatsoever of the future value of the Company’s common stock or its financial value. The Company's filings may be accessed at the OTC Market’s disclosures at www.otcmarkets.com. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
| Contact: |
| StemSation International Benjamin Silber BSilber@stsninc.com |